Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics is organized by CME Science and will be held from Oct 22-23, 2026 at Wynn Las Vegas, Las Vegas, Nevada, United States of America.
Objectives:
This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
At the conclusion of this course, participants will be able to:
With the recent approval by CMS Medicare for DOTATATE (NETSPOT) PET/CT and the rapid international adoption of targeted Lu-177 based therapies for neuroendocrine and prostate cancers, it is clear that Nuclear Medicine and PET/CT are entering into a new era. New diagnostic and therapeutic agents with remarkable sensitivity and specificity are revolutionizing Nuclear Medicine and Oncology. This course will highlight the latest targeted imaging agents for neuroendocrine and prostate cancers (Ga-68 DOTATATE and Ga-68 PSMA PET/CT) as well as review important core concepts in PET/CT imaging and therapeutic Nuclear Medicine.
Accreditation:
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and CME Science. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
PACE designates this live activity for 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to PACE policies.
Technologists:
This course is pending approval for up to 16 ARRT Category A CE credits for those technologists attending the entire course
Cancellations received at least 30 days in advance are subject to a $100 cancellation fee or may be exchanged for their full value for a voucher for future use for any live, webinar, or on-demand course that takes place within 13 months of the canceled course. Cancellations received less than 30 days before the start of the course are non-refundable but may be exchanged for their full value for a voucher for future use for any live, webinar, or on-demand course that takes place within 13 months of the canceled course.
In-Person attendees have the option of being in the meeting room or viewing the live broadcast from their guest rooms, or any space with WI-Fi.
All Registrants, In-Person and Live Webinar have access to the webinar for six months.
Webinar access is available for 6 months after the conclusion of the live presentations. CME credit must be claimed within 1 month after the course concludes.
Webinar access is strictly for the registrant only. Sharing access without permission may void your CME eligibility and/or close your access and is a violation of your purchase agreement. If you would like to share access, please contact us.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved